Menu Search
Equities

Illumina Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
ILMN:VIE

Illumina Inc

Actions
  • Price (EUR)112.06
  • Today's Change0.12 / 0.11%
  • Shares traded0.00
  • 1 Year change+31.65%
  • Beta1.4621
Data delayed at least 15 minutes, as of Mar 02 2026.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.

  • Revenue in USD (TTM)4.34bn
  • Net income in USD850.00m
  • Incorporated2000
  • Employees8.60k
  • Location
    Illumina Inc5200 Illumina WaySAN DIEGO 92122United StatesUSA
  • Phone+1 (302) 658-7581
  • Fax+1 (302) 655-5049
  • Websitehttps://www.illumina.com
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		ILMN:NSQ since
announced		Transaction
value
Somalogic IncDeal completed23 Jun 202523 Jun 2025Deal completed46.86%425.00m
Data delayed at least 15 minutes, as of Mar 02 2026 21:00 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.